NeuroMetrix, Inc.
NURO · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $583 | $587 | $769 | $1,094 |
| % Growth | -0.8% | -23.6% | -29.7% | – |
| Cost of Goods Sold | $224 | $275 | $277 | $577 |
| Gross Profit | $359 | $312 | $492 | $517 |
| % Margin | 61.6% | 53.1% | 64% | 47.3% |
| R&D Expenses | $282 | $300 | $267 | $944 |
| G&A Expenses | $1,634 | $1,313 | $1,619 | $1,766 |
| SG&A Expenses | $2,034 | $1,754 | $2,054 | $2,827 |
| Sales & Mktg Exp. | $400 | $441 | $435 | $1,062 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,316 | $2,054 | $2,321 | $3,771 |
| Operating Income | -$1,957 | -$1,742 | -$1,829 | -$3,254 |
| % Margin | -335.8% | -296.6% | -237.8% | -297.6% |
| Other Income/Exp. Net | $177 | $234 | $341 | $224 |
| Pre-Tax Income | -$1,780 | -$1,508 | -$1,488 | -$3,030 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,780 | -$1,508 | -$1,488 | -$3,030 |
| % Margin | -305.5% | -256.8% | -193.5% | -277% |
| EPS | -0.87 | -0.75 | -0.74 | -1.67 |
| % Growth | -16% | -1.4% | 55.7% | – |
| EPS Diluted | -0.87 | -0.75 | -0.74 | -1.67 |
| Weighted Avg Shares Out | 2,051 | 2,023 | 2,001 | 1,812 |
| Weighted Avg Shares Out Dil | 2,051 | 2,023 | 2,001 | 1,812 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $8 | $13 | $19 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $56 | $60 | $92 | $25 |
| EBITDA | -$1,724 | -$1,682 | -$1,737 | -$3,229 |
| % Margin | -295.8% | -286.4% | -225.8% | -295.3% |